These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
    Author: Yao Z, Xu Y, Zhang M, Jiang S, Nicklaus MC, Liao C.
    Journal: Bioorg Med Chem Lett; 2011 Jan 01; 21(1):475-8. PubMed ID: 21094046.
    Abstract:
    Finasteride and epristeride both inhibit 5α-reductase with high potency via competitive and non-competitive mechanism, respectively. A new hybrid of finasteride and epristeride was designed as a new 5α-reductase inhibitor based on combination principles in medicinal chemistry. Human 5β-reductase was chosen as a plausible surrogate of 5α-reductase type II and the results indicate that although the hybrid compound possesses the main bulk of epristeride, its inhibitory mechanism is same as of finasteride. The hybrid turned out to be a potent 5α-reductase inhibitor in low IC(50) ranges.
    [Abstract] [Full Text] [Related] [New Search]